Header Logo

Connection

RENE GONZALEZ to Triple Negative Breast Neoplasms

Back to Details
This is a "connection" page, showing publications RENE GONZALEZ has written about Triple Negative Breast Neoplasms.
RENE GONZALEZ
Connection Strength
0.134
Triple Negative Breast Neoplasms
  1. Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors. Cancer Chemother Pharmacol. 2020 04; 85(4):673-683.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.